We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current LIPO market cap is 3.59M. The company's latest EPS is USD -0.6073 and P/E is -0.91.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 118k | 107k | 104k | 121k | 146k |
| Operating Income | -1.09M | -1.57M | -1.36M | -730k | -1.22M |
| Net Income | -1.07M | -1.54M | -1.32M | -689k | -1.19M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 962k | 259k | 184k | 450k |
| Operating Income | -57k | -1.92M | -2.59M | -4.75M |
| Net Income | -62k | -1.87M | -2.6M | -4.62M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 4.62M | 3.49M | 2.84M | 3.58M | 3.14M |
| Total Liabilities | 799k | 364k | 619k | 433k | 576k |
| Total Equity | 3.82M | 3.13M | 2.22M | 3.14M | 2.56M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 955k | 2.01M | 5.95M | 3.58M |
| Total Liabilities | 492k | 589k | 1.27M | 433k |
| Total Equity | 463k | 1.42M | 4.68M | 3.14M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -1.08M | -1.73M | -2.42M | -3.15M | -1.39M |
| Investing | N/A | N/A | -14k | -14k | N/A |
| Financing | -25k | -275k | -275k | 1.34M | 200k |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -28k | -989k | -1.83M | -3.15M |
| Investing | N/A | -301k | 301k | -14k |
| Financing | 609k | 2.1M | 5.24M | 1.34M |
| Market Cap | 3.59M |
| Price to Earnings Ratio | -0.91 |
| Price to Sales Ratio | 9.29 |
| Price to Cash Ratio | 1.27 |
| Price to Book Ratio | 1.33 |
| Dividend Yield | - |
| Shares Outstanding | 7.61M |
| Average Volume (1 week) | 35.35k |
| Average Volume (1 Month) | 58.64k |
| 52 Week Change | -76.61% |
| 52 Week High | 2.71 |
| 52 Week Low | 0.4004 |
| Spread (Intraday) | 0.04 (7.62%) |
| Company Name | Lipella Pharmaceuticals Inc |
| Address |
108 west 13th street wilmington, delaware 19801 |
| Website | https://www.lipella.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
